Nanoflex Robotics Appoints Per Vegard Nerseth, Former CMR Surgical CEO, as Non-Executive Director
05 Agosto 2024 - 5:16AM
Nanoflex Robotics is pleased to announce that it has appointed Per
Vegard Nerseth, the former Chief Executive Officer of CMR Surgical,
as an independent Non-Executive Director effective immediately.
Per Vegard brings over three decades of global business
experience, including developing high-performing teams and
launching new ventures in the robotics sector. Most recently, Per
Vegard was the CEO of CMR Surgical, where he also served on the
Board. Prior to CMR Surgical, Per Vegard held multiple portfolios
at ABB, where he steered business lines’ turnarounds and optimized
for long-term strategic growth.
Per Vegard’s track record of navigating complex markets and
scaling cutting-edge technologies makes him a crucial addition to
Nanoflex Robotics’s Board. His expertise is especially valuable as
the company looks to accelerate the development of its innovative
telerobotics system to treat acute ischemic stroke and bring it to
market.
"We are thrilled to welcome Per Vegard to our Board. His
extensive leadership experience and deep understanding of complex
regulatory markets will be invaluable to Nanoflex Robotics as we
aim to complete our first-in-human procedures next year and
commence clinical studies thereafter," said Matt Curran, CEO of
Nanoflex Robotics.
"I am honored to join the Board of Nanoflex Robotics. I admire
the company’s big vision in developing a telerobotic platform to
treat acute ischemic stroke. I look forward to contributing to the
company’s future success and working with such a talented and
dedicated team," said Per Vegard Nerseth.
Nanoflex Robotics is a Swiss medical device startup that aims to
enhance accessibility to life-saving interventions through
telerobotics. The first application of the company’s Remote
Intervention System (RIS) is to enable a remote thrombectomy for
patients suffering from acute ischemic stroke. The RIS is currently
undergoing final product refinement and pre-clinical testing with
the aim of conducting its first-in-human procedure in 2025.
About Nanoflex Robotics AGNanoflex Robotics is
building a next-generation telerobotics interventional platform to
enhance access to life-saving procedures. The first target
application of the Remote Intervention System (RIS) is to enable
telerobotic mechanical thrombectomies in acute ischemic stroke
patients where timely intervention is critical. The RIS combines
unique advanced magnetic navigation technology and ultra-flexible
endoluminal robotic tools to give physicians greater control and
dexterity over procedures, allowing for safer and more precise
interventions that enhance patient care, reduce complications, and
improve overall outcomes. To learn more, please visit:
www.nanoflexrobotics.com
For media inquiries, please contact:
ir[at]nanoflexrobotics.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/5471ec13-723a-4781-9aa9-360409c13a18